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1. Introduction
  Malaria continues to cause morbidity and mortality on 
a large scale in tropical countries. The alarming rate at 
which the parasite, particularly Plasmodium falciparium 
(P. falciparium), has developed resistance to currently used 
antimalarial drugs makes it imperative to search for newer, 
more effective therapeutic agents. The selection of plants 
to be screened for antimalarial activity is done on the basis 
of traditional reputation of particular plants for efficacy 
in the treatment of malaria. Malaria is Africa’s leading 
causes of under five mortality and constitutes 10% of the 
continents overall disease burden, malaria accounts for 40% 
of public health expenditure, 30% to 50% inpatient and up 
to 50% out-patient in areas with high malaria transmission. 
The global strategy for malaria mainly focuses on case 
management through provision of drugs capable of reducing 
the morbidity and mortality or eliminating parasites[1,2]. 
Despite the increase threat of malaria to lives especially 
in Africa, success in controlling the disease is possible[3]. 
Different approaches are currently being advocated 
to achieve this which includes: exploring evidence of 
immunity, revisiting the abandoned vector control methods 
and investigation into traditionally used herbal medicines[4].
  Aspilia africana (A. africana) (Pers.) C.D. Adams 
(Asteraceae) is commonly found in tropical West Africa. 
This plant is commonly referred to as “hemorrhage plant” 
due to its ability to stop blood flow from fresh wounds, 
and has several uses in traditional medical practice. The 
crushed leaves have been used for patients suffering 
from rheumatic pains and to clean surfaces of sores by 
absorption of exudates[5]. Wound healing occurs when 
treated with the crushed leaves[6]. An infusion of the leaves 
of this plant is usually taken by pregnant women at child 
birth and used as cough remedy in children. A. africana is 
also used for traditional treatment of malaria symptoms in 
East and Central Africa[7]. The antibacterial activity of the 
leaf extract has been reported[8].
  This study aimed at evaluating the antimalarial activity of 
ethanol leaf extract of A. africana on P. berghei infection in 
mice.
Objective: To investigate the antimalarial activity of ethanol extract of Aspilia africana
(A. africana) leaf. Methods: The ethanol extract of A. africana leaf (100-400 mg/kg) was 
screened for blood schizonticidal effect against chloroquine-sensitive Plasmodium berghei (P. 
berghei) in mice both in early and established models of antimalarial studies. Results: The leaf 
extract exhibited significant (P<0.05) antiplasmodial activity in 4-day early infection and in 
established infection tests with a considerable mean survival time comparable to that of standard 
drug, chloroquine (10 mg/kg). Conclusions: The findings show that ethanol extract of A. africana 
leaf possesses potent antiplasmodial activity which justify the use in ethnomedicine and can be 
developed in malaria therapy.
Akuodor Godwin Christian et al./Asian Pacific Journal of Tropical Medicine (2012)126-129 127
2. Materials and methods 
2.1. Collection and preparation of plant materials
  Fresh leaves of A. africana were collected from plants 
growing within the campus of University of Calabar, Cross 
River State, Nigeria. The plant material was identified and 
authenticated by Mr. F.I. Apejoye of Botany Department, 
University of Calabar, where a voucher specimen (No. 252) 
is maintained. The international plant number index is 
Asteraceae A. africana (pers.) C.D. Adams-Webbia X11.236 
(1956) (Ik).
  The leaves were cleaned, cut into smaller pieces, air-dried 
at room temperature for 7 days and pulverized to dry powder 
using a mortar and pestle.
2.2. Extraction of plant material
  Three hundred and fifty grams of the dry leaf powder was 
extracted with ethanol by maceration for 48 h with constant 
shaking. The resultant filtrate was dried on water bath to 
obtain 32 g (9.1% w/w) of ethanol extract. The leaf extract 
was subsequently reconstituted in water at appropriate 
concentrations for the experiment.
2.3. Phytochemical screening
  The ethanol leaf extract of A. africana was subjected to 
phytochemical analysis for identification of constituents 
using conventional protocols[9,10].
2.4. Animals
  Swiss albino mice (18-22 g) of both sexes obtained from 
the Animal Facility Centre, NIPRD, Abuja, were used for 
the study. The animals were housed in aluminum cages at 
room temperature and moisture, under naturally illuminated 
environment of 12:12 h dark/light cycle. They were fed on 
standard diet and had water ad libitum. The mice were 
used in accordance with NIH Guide for the care and use 
of Laboratory Animals[11], NIPRD-Standard Operation 
Procedures.
2.5. Acute toxicity test
  The LD50 of the plant extract was tested to determine the 
safety of the agent using Lorke’s method. The study was 
carried out in two phases. In the first phase, nine mice were 
randomized into three groups of three per cage and were 
administered 10, 100 and 1 000 mg/kg of the leaf orally. The 
mice were observed for signs of toxicity which include paw 
licking, salivation, stretching of the entire body, weakness, 
sleep, respiratory distress, coma and death in the first four 
hours and subsequently for 4 days. In the second phase, 
another set of nine mice were also randomized into three 
groups of three mice per cage and were administered 1 600, 
2 900 and 5 000 mg/kg of the leaf extract orally, based on 
the result of the first phase. The animals were also observed 
for signs of toxicity and mortality for the first four hours 
and thereafter for 4 days. The oral LD50 was calculated as 
the geometric mean of the highest non-lethal dose and the 
lowest lethal dose.
2.6. Inocula
  Parasitized erythrocytes were obtained from a donor 
infected mouse maintained at Animal Facility Centre, 
NIPRD, Abuja, Nigeria. Parasites are maintained by 
continuous reinfestation in mice. The inoculums consisted 
of P. berghei parasitized erythrocytes. This was prepared 
by determining both the percentage parasitemia and 
the erythrocytes count of the donor mouse and diluting 
them with normal saline in proportions indicated by both 
determinations. Each mouse was inoculated intraperitoneally 
with infected blood suspension (0.2 mL) containing 1伊107 
P. berghei parasitized red blood cells.
2.7. Suppressive test
  A 4-day suppressive test was performed using the methods 
of David et al[12-14]. Thirty Swiss albino mice of both sexes 
weighing (18-22 g) were inoculated by intraperitoneal 
injection with standard inoculums of P. berghei containing 
1伊107 infected erythrocytes. The mice were randomly divided 
into 5 groups of 6 per cage and treated for 4 consecutive 
days with 100, 200 and 400 mg/kg of the extract, chloroquine 
10 mg/kg and 0.2 mL normal saline, all administered orally. 
On the fifth day, blood was collected from the tail of each 
mouse and thin films made on a slide. The films were 
fixed with methanol, stained with Giemsa and parasitemia 
density examined by microscopically (Nikon YS2-H, Japan) 
counting the parasitized red blood cells on at least 1 000 red 
blood cells in 10 different fields.
2.8. Curative test
  Evaluation of curative potential of A. africana leaf extract 
was done adopting the method described by Ryley et al 
with slight modification. Thirty mice were selected and 
intraperitoneally injected with 1伊107 P. berghei infected 
erythrocytes on the first day. Seventy two hours after, the 
mice were grouped into 5 groups of 6 per cage and treated 
with 100, 200 and 400 mg/kg of the extract, chloroquine
10 mg/kg and 0.2 mL normal saline, all administered orally. 
Treatment continued daily until the seventh day when 
thin films were prepared with blood collected from the 
tail of each mouse. The films were fixed with methanol, 
stained with Giemsa and parasitemia density examined by 
microscopically counting the parasitized red blood cells on 
at least 1 000 red blood cells in 10 different fields.
2.9. Statistical analysis
  Results obtained were expressed as mean依SEM. The 
data was analyzed using one-way ANOVA and differences 
between mean were considered significant when P< 0.05[15].
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3. Results
3.1. Phytochemical test
  Phytochemical screening of the ethanol extract of 
A. africana leaf revealed the presence of terpenes, steroids, 
flavonoids, alkaloids, volatile oils and carbohydrates. 
These classes’ compounds are reported to show important 
biological activities[16,17].
3.2. Acute toxicity test
  There was no mortality observed in mice after oral 
administration of the ethanol extract even at doses as high 
as 5 000 mg/kg signifying that the oral LD50 was 5 000 mg/kg. 
Thus the experimental doses used (100, 200 and 400 mg/kg 
p.o.) were within safe margin.
3.3. Suppressive effect
  The ethanol extract of A. africana leaf exerted dose-
dependent chemosuppressive effect at the various doses 
employed in this study (100, 200 and 400 mg/kg), with 
a chemosuppression of 79.42%, 84.28% and 92.23% 
respectively. The effect of this extract was significantly 
(P<0.05) when compared with the control. The standard 
drug, chloroquine (10 mg/kg), caused 95.30% suppression 
(Table 1).
3.4. Effect of the extract on established infection
  Treatment of the P. berghei infected mice with the leaf 
extract of A. africana exhibited a dose-dependent daily 
decrease in parasitemia in the extract treated group similar 
to chloroquine-treated group unlike in the saline group in 
which there was a consistent increase in the blood parasite 
density. The mean survival time also increased dose-
dependently. Death was observed in the control group on 
day 8, and by day 12, all mice in the group died. On the 
other hand, mice in the groups treated with 100, 200 and 
400 mg/kg survived beyond 21 days. Chloroquine treated 
group survived the 30 days duration of observation (Table 2).
Table 2
Curative effect of A. africana in P. berghei-infected mice.
Treatment Dose (mg/kg)
Mean parasitemia density
Survival time (Days)
Pre (D3) Post (D7)-treatment
Control 0.2  mL/kg 32.25依3.28 40.32依2.40 12.00依2.30
A. africana 100 29.30依2.33   8.47依0.82   22.10依1.20*
200 30.42依3.10   6.80依0.27   25.00依1.00*
400 31.38依4.20   4.93依0.47   28.20依0.50*
CQ   10 29.28依2.00   2.56依0.32   30.00依0.00*
*Significantly different from control at P<0.05. D3=Day three, D7=Day seven, CQ=Chloroqiune.
4. Discussion
  The results show that A. africana leaf extract has negligible 
toxicity, as shown in the LD50 value of 5 000 mg/kg.
The results also show that the leaf extract possess 
significant antimalarial activity which was evident from 
the chemosuppression it produced during the 4-day early-
infection test. The rodent parasite, P. berghei has been used 
in studying the activity of potential antimalarials in mice[18] 
and in rats[19]. It produces diseases similar to those of human 
plasmodial infection[20,21]. Rodent models of antimalarial 
study have been validated through the identification 
of several conventional antimalarials especially with 
the success of quinine and more recently artemisinin 
derivatives[22]. Our investigation of the scientific reasons 
behind the folkloric use of A. africana in the treatment 
of malaria attack in traditional African setting can be 
partially satisfied with this result[23]. In addition, the result 
of chemosuppressive study can be interpreted to be that 
the leaf extract of this plant can suppress parasite growth to 
non-detectable levels in erythrocytes. It is important that 
scientific evaluation of traditional medicine preparations for 
claimed antimalarial efficacy be carried out even up to the 
level of finding out the degree of suppression of growth in 
erythrocytes[24].
  The leaf extract of this plant also exerted significant 
curative effect during established infection. Curative activity 
of potential antimalarial agents of ethnobotanical materials 
should be discernable during testing for antimalarial 
properties. The observed antimalarial activity of the plant 
extract is consistent with the traditional use of the plant 
as herbal medication against the disease and indicative 
of its potential as a chemotherapeutic antimalarial agent. 
This was confirmed by the mean survival time values 
which at employed doses were twice or more than that of 
control group. In the untreated mice, the parasitemia count 
increased daily until the death of the animals, which was 
also observed in our previous studies[25].
Table 1
Suppressive activity of A. africna in P. berghei-infected mice.
Treatment Dose (mg/kg) Mean parasitemia density (D5)
Control 0.2 mL/kg 32.56依0.38
A. africana 100     6.70依0.20*
200     5.12依0.50*
400     2.53依0.27*
CQ   10     1.53依0.26*
*Significantly different from control at P<0.05. D5=Day five, 
CQ=Chloroquine.
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  The antiplasmodial activity of this plant extract might 
be attributed to the presence of alkaloids, flavonoids 
and terpenes which have been variously implicated in 
antiplasmodial activities of many plants[26-28].  However, 
the active compounds known to exert the observed activity 
need to be identified. Some plants are known to exhibit 
antiplasmodial activity by either causing red blood cell 
oxidation or by inhibiting protein synthesis depending on 
their phytochemical constituents. These compounds may 
be acting singly or in synergy with one another to exert 
antiplasmodial activity observed in the study.
  This study has however, established the rationale for 
the traditional use of this plant in Nigeria and like many 
others, showed that medicinal plants which have folkloric 
reputations for antimalarial properties can be investigated 
in order to establish their efficacy and to determine their 
potentials as sources of new antimalarial drug.
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